Orchestration of tertiary lymphoid structures: decoding developmental mechanisms for next-generation cancer immunotherapies
Open Access
- 12 September 2025
- journal article
- research article
- Published by Walter de Gruyter GmbH in Medical Review
- Vol. 5 (5) , 421-424
Abstract
Tertiary lymphoid structures (TLSs) are ectopic lymphoid aggregates that form in non-lymphoid organs, frequently observed in conditions such as cancer, autoimmune diseases, transplant rejection, and chronic inflammation. Growing evidence suggests that TLSs are beneficial for patients’ prognosis with higher TLS density generally correlating with improved therapeutic response and survival outcomes across malignancies and might serve as a novel therapeutic target for cancer immunotherapy. However, the correlation between TLSs and tumor development is still ambiguous. The exact timing of TLS formation during tumorigenesis and their dynamic evolution throughout tumor progression remain under investigation. Recent studies have identified potential strategies for inducing TLSs, but there remains a considerable distance from clinical application. More advanced techniques such as high-resolution spatial multi-omics technologies combined with big data analysis will benefit understanding the complex interactions within TLSs and developing novel immunotherapies.Keywords
This publication has 15 references indexed in Scilit:
- IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancerNature, 2025
- The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactionsCancer Cell, 2024
- Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advancesSignal Transduction and Targeted Therapy, 2024
- CCL19-producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor IgG response in colorectal cancer liver metastasisCancer Cell, 2024
- Tertiary lymphoid structures in anticancer immunityNature Reviews Cancer, 2024
- Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancerImmunity, 2022
- Epigenomic Reprogramming toward Mesenchymal-Epithelial Transition in Ovarian-Cancer-Associated Mesenchymal Stem Cells Drives MetastasisCell Reports, 2020
- CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal AdenocarcinomaCancer Cell, 2016
- Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinomaNature Immunology, 2015
- Mucins in pancreatic cancer and its microenvironmentNature Reviews Gastroenterology & Hepatology, 2013